Canada and Mexico tariffs will take effect March 4, Trump confirms

The president will also impose an additional 10% import tax on China next week and hinted at plans to soon levy 25% duties on the European Union.

By Philip Neuffer • Feb. 27, 2025

Teleflex to split in 2, buy Biotronik assets for $791M among slew of actions

Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also announced a CFO transition.

By Susan Kelly • Feb. 27, 2025

Explore the Trendline➔

Medical device industry continues to turn to AI

While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

By MedTech Dive staff

Tandem’s insulin pump tech wins FDA nod for Type 2 diabetes

Tandem is following competitor Insulet’s lead with the second automated insulin delivery system indicated for Type 2 diabetes.

By Elise Reuter • Feb. 27, 2025

Elekta CEO Gustaf Salford to leave after board sees need for new leader

Laurent Leksell, Elekta’s chairman of the board, said the company needs “new leadership that can further intensify the focus on improving profitability and strengthen growth.”

By Nick Paul Taylor • Feb. 27, 2025

Staar Surgical to lay off 115 people in California

Staar’s job cuts come “amid ongoing macroeconomic and geopolitical challenges that have pressured the business,” a spokesperson said. Demand in China, the company’s largest market, has slowed.

By Susan Kelly • Feb. 26, 2025

CAP urges HHS to revoke lab developed test rule, citing Trump order

The pathologists group wants the regulation terminated in light of an executive order from President Trump that calls for federal agencies to “alleviate unnecessary regulatory burdens.”

By Nick Paul Taylor • Feb. 26, 2025

Thermo Fisher to buy Solventum’s purification and filtration unit for $4.1B

Wall Street applauded the deal, sending shares of Solventum, the 3M spinoff, up 10% on Tuesday.

By Susan Kelly • Feb. 25, 2025

FDA brings back some fired device staff

An industry source said “most, if not all” of the people at the CDRH who were recently dismissed are now being asked to return.

By Elise Reuter • Feb. 24, 2025

Medtronic gains FDA OK for self-adjusting DBS system for Parkinson’s

The brain-computer interface technology personalizes therapy based on an individual’s brain activity.

By Susan Kelly • Feb. 24, 2025

After tough year, Baxter looks for next CEO to drive growth

Interim CEO Brent Shafer said the medical products maker is ready to begin a new era after several years of “heavy lifting” to simplify the business structure.

By Susan Kelly • Feb. 21, 2025

VitalConnect raises $100M for heart monitor patch

VitalConnect will use the money to commercialize the monitor, which detects arrhythmias and competes with patches from companies including iRhythm.

By Nick Paul Taylor • Feb. 21, 2025

Siemens Healthineers opening logistics depots in US to boost inventory

Expanding parts inventory and logistics capabilities will support later cutoff times, same-day delivery within 300 miles and more next-flight-out options for customers, the company said.

By Nick Paul Taylor • Feb. 20, 2025

Device industry scrambles as FDA job cuts cause delays

The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an attorney said.

By Elise Reuter • Feb. 20, 2025

Advamed CEO warns FDA job cuts put patients, industry at risk

Scott Whitaker sent a letter to the HHS calling for staff cuts at the FDA to be reversed, arguing patient care and U.S. leadership in medtech are on the line.

By Susan Kelly • Feb. 19, 2025

Vicarious Surgical COO John Mazzola to retire

Mazzola’s retirement plan comes less than two months after CFO William Kelly left the surgical robot developer.

By Susan Kelly • Feb. 19, 2025

Medtech firms have little to say on Trump tariffs

Wall Street analysts said current tariffs should be “manageable” for the sector but cautioned that other countries may retaliate.

By Elise Reuter • Feb. 19, 2025

Philips expects sales struggles in China to continue in 2025

Philips forecast a double-digit sales decline in China for the first half of 2025 after reporting “significant deterioration” of demand in October.

By Nick Paul Taylor • Feb. 19, 2025

J&J resumes PFA cases, but analysts warn safety may hamper rollout

J.P. Morgan analysts said the findings of J&J’s investigation “could significantly hinder the product’s rollout in the U.S. and globally” and lead doctors to “de-prioritize Varipulse.”

By Nick Paul Taylor • Feb. 18, 2025

Mitigating tariffs: EY’s Lynlee Brown discusses strategies for medtech

Lynlee Brown, a global trade partner at EY, outlined several strategies for device manufacturers to offset fast-moving tariffs.

By Elise Reuter • Feb. 18, 2025

Medtronic buys Nanovis’ nano technology for use in spine implants

Medtronic will use the technology to develop PEEK interbody spine fusion devices that enhance implant fixation.

By Nick Paul Taylor • Feb. 13, 2025

Judge orders FDA, health agencies to restore removed webpages

District Judge John Bates wrote the removals harm “everyday Americans, and most acutely, underprivileged Americans, seeking healthcare.”

By Elise Reuter • Feb. 12, 2025

Edwards predicts second-half lift from TAVR label expansion

Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this year.

By Susan Kelly • Feb. 12, 2025

How Trump’s trade fight could impact the medtech industry

Relocating manufacturing would require substantial capital investment, but the timespan for the president’s new tariffs is unclear, supply chain experts said.

By Susan Kelly • Feb. 12, 2025

EMA creates advice portal for some high-risk medical devices

The European Medicines Agency said the portal will enable consultations with medical device expert panels that can promote faster access to new technologies. 

By Nick Paul Taylor • Feb. 12, 2025

Inspire Medical reveals DOJ civil investigation

CEO Tim Herbert told investors the company received a civil investigative demand from the Department of Justice in January for information on marketing and reimbursement practices.

By Ricky Zipp • Feb. 11, 2025